查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933371

全球移植診斷市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Transplant Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

移植診斷市場的成長驅動因素

全球移植診斷市場在確保器官和幹細胞移植成功方面發揮關鍵作用，它能夠實現精準的供體-受體匹配和有效的移植後監測。 2025年，全球移植診斷市場價值為26.9億美元，預計2026年將成長至28.2億美元，到2034年將達到44.5億美元，預測期內複合年增長率為5.89%。北美地區在2025年佔市場主導地位，佔全球市場佔有率的58.43%，這得益於其先進的醫療基礎設施和龐大的移植手術量。

移植診斷包括分子和免疫學檢測，例如 HLA 分型、交叉配對、供體特異性抗體篩檢和排斥反應監測。這些診斷對於最大限度地減少器官排斥反應、優化免疫抑制療法以及改善長期移植效果至關重要。對精準醫療和分子診斷的投入不斷增加，進一步推動了市場成長。

市場動態

市場驅動因素

器官移植手術數量的增加以及對相容性檢測的需求

由於末期腎病、肝衰竭和心臟病等慢性疾病的增加，全球對器官移植的需求顯著增長。這種成長直接推動了對先進移植診斷檢測的需求，以確保供體和受體的相容性以及移植後的成功。

例如，根據英國腎臟護理協會2024年的報告，英國約有6250人在等待腎臟移植。 PCR、次世代定序（NGS）和生物標記檢測等技術的應用，使得更早發現排斥反應和改善臨床決策成為可能，從而進一步推動了市場成長。

市場限制因子

捐贈器官短缺

儘管技術不斷進步，供體器官短缺仍然是一個主要限制因素。移植候選人的數量遠遠超過可用捐贈者器官的數量，導致移植手術數量下降，診斷檢測的使用率也隨之下降。

根據美國捐贈生命組織（Donate Life America）統計，美國每年約有5600人在等待器官移植的過程中死亡，這凸顯了供需缺口對市場成長的間接限製作用。

市場機會

移植基礎建設投資增加

對移植中心和醫療基礎設施的投資增加帶來了巨大的成長機會。各國政府和私營機構都在積極宣傳器官捐獻，並致力於擴大移植設施。

例如，維多利亞醫院於2025年4月宣佈在印度班加羅爾開設一家新的器官採集和移植中心。該投資金額將達110萬美元，以滿足未來對移植診斷的需求。

市場挑戰

嚴格的監管和報銷政策

嚴格的監管要求和有限的報銷範圍給市場擴張帶來了挑戰。移植診斷必須滿足高安全性和高準確性標準，這導致審批流程漫長且研發成本高昂。此外，許多地區的部分報銷制度限制了移植診斷的普及，尤其是在發展中國家。

市場趨勢

轉型為非侵入性監測

移植診斷市場的關鍵趨勢是非侵入性診斷技術的日益普及。基於血液的生物標記檢測和基於定序的檢測方法減少了侵入性活檢的需求，從而能夠早期發現排斥反應，同時最大限度地降低患者風險。

2024年6月，Omixon的NanoTYPE HLA擴增試劑盒獲得IVDR批准，這標誌著市場正向先進的微創檢測解決方案發生重大轉變。

細分市場分析

依類型劃分

試劑和耗材細分市場在2026年佔主導地位，市佔率達67.33%，主要得益於移植診斷中試劑盒和試劑的持續使用。由於新興經濟體移植基礎設施的擴張，設備細分市場預計將保持穩定成長。

依檢測方法

移植後反覆進行的排斥反應監測，旨在確保移植器官的長期存活，佔了最大的市場佔有率（預計2026年將達到46.46%）。

依技術方法

由於其成本效益和廣泛應用，PCR技術預計在2026年將佔26.71%的市場佔有率。 同時，由於其卓越的準確性和在個人化醫療中的重要作用，次世代定序 (NGS) 預計將實現最高的成長率。

依移植類型劃分

受需要器官移植的慢性疾病高發生率的推動，實體器官移植領域預計將在 2026 年佔市場主導地位，市場佔有率高達 95.21%。

依最終使用者劃分

由於醫院和移植中心移植手術集中度高且擁有先進的診斷基礎設施，因此它們佔了最大的市場佔有率。

區域展望

預計到 2025 年，北美地區的收入將達到 15.7 億美元，這主要得益於強有力的政府舉措、先進診斷技術的廣泛應用以及龐大的移植患者群體。 由於強大的研究合作，預計歐洲將呈現穩定成長；而由於慢性病負擔加重以及印度、中國和日本移植計畫的擴張，預計亞太地區將實現最高的複合年增長率。由於醫療基礎設施的改善，預計拉丁美洲和中東及非洲地區將實現溫和成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要疾病流行情況、主要國家和地區（2025/2026 年）
  • 移植診斷技術進展
  • 新產品發布、主要參與者
  • 關鍵產業趨勢－併購及合作關係

第五章 全球移植診斷市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 儀器
    • 試劑與耗材
    • 軟體與服務
  • 市場分析、洞察與預測：依檢測項目劃分
    • HLA分型
    • 交叉偵測
    • 供體特異性抗體（DSA）篩檢
    • 排斥反應監測
    • 感染與移植監測
  • 市場分析、洞察與預測：依技術劃分
    • PCR
    • 次世代定序
    • Sanger測序
    • 流式細胞儀
    • 血清學檢測檢測
    • 其他
  • 市場分析、洞察與預測：依移植類型劃分
    • 實體器官移植
      • 腎臟移植
      • 肝臟移植
      • 肺臟移植
    • 幹細胞/骨髓移植
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院及移植中心
    • 研究機構和學術機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美移植診斷市場分析：洞察與預測 （2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲移植診斷市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章 亞太地區移植診斷市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳大利亞
    • 中國
    • 印度
    • 東南亞
    • 南亞韓國
    • 亞太其他地區

第九章：拉丁美洲移植診斷市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲移植診斷市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 南非
    • 海灣合作委員會
    • 中東和非洲其他地區

第十一章：競爭分析

  • 全球市佔率分析（2025）
  • 公司型材
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Thermo Fisher Scientific
  • Qiagen
  • Admera Health, LLC
  • Bio-Rad Laboratories Inc.
  • Bruker
  • Werfen
  • BD
  • Other Prominent Players
Product Code: FBI114084

Growth Factors of transplant diagnostics Market

The global transplant diagnostics market plays a crucial role in ensuring the success of organ and stem cell transplantation by enabling accurate donor-recipient matching and effective post-transplant monitoring. In 2025, the global transplant diagnostics market was valued at USD 2.69 billion and is projected to grow to USD 2.82 billion in 2026, reaching USD 4.45 billion by 2034, registering a CAGR of 5.89% during the forecast period. North America dominated the market in 2025, accounting for 58.43% of the global share, driven by advanced healthcare infrastructure and a high number of transplant procedures.

Transplant diagnostics include molecular and immunological tests such as HLA typing, crossmatch testing, donor-specific antibody screening, and rejection monitoring. These diagnostics are essential to minimize organ rejection, optimize immunosuppressive therapy, and improve long-term transplant outcomes. Rising investments in precision medicine and molecular diagnostics are further strengthening market growth.

Market Dynamics

Market Drivers

Rising Organ Transplant Procedures and Need for Compatibility Testing

The increasing prevalence of chronic diseases such as end-stage kidney disease, liver failure, and heart disorders has significantly increased the demand for organ transplants worldwide. This rise has directly increased the need for advanced transplant diagnostic tests to ensure donor-recipient compatibility and post-transplant success.

For instance, in 2024, Kidney Care U.K. reported that approximately 6,250 people were on the kidney transplant waiting list in the U.K. The adoption of technologies such as PCR, next-generation sequencing (NGS), and biomarker testing has enabled early detection of rejection and improved clinical decision-making, further driving market growth.

Market Restraints

Limited Availability of Donor Organs

Despite technological advancements, the limited availability of donor organs remains a major restraint. The number of transplant candidates significantly exceeds the number of available donor organs, resulting in fewer transplant procedures and reduced utilization of diagnostic tests.

According to Donate Life America, around 5,600 people in the U.S. die annually while waiting for an organ transplant, highlighting the gap between demand and supply, which indirectly restricts market growth.

Market Opportunities

Rising Investments in Transplant Infrastructure

Growing investments in transplant centers and healthcare infrastructure provide significant growth opportunities. Governments and private institutions are actively promoting organ donation awareness and expanding transplant facilities.

For example, in April 2025, Victoria Hospital announced the launch of a new organ retrieval and transplant center in Bengaluru, India, with an investment of USD 1.1 million, supporting future demand for transplant diagnostics.

Market Challenges

Stringent Regulatory and Reimbursement Policies

Strict regulatory requirements and limited reimbursement coverage pose challenges to market expansion. Transplant diagnostics must meet high safety and accuracy standards, leading to lengthy approval timelines and high development costs. Additionally, partial reimbursement in many regions limits adoption, especially in developing economies.

Market Trends

Shift Toward Non-Invasive Monitoring

A major trend in the transplant diagnostics market is the growing adoption of non-invasive diagnostic technologies. Blood-based biomarker tests and sequencing-based assays reduce the need for invasive biopsies and allow early detection of rejection with minimal patient risk.

In June 2024, Omixon received IVDR approval for its NanoTYPE HLA amplification kit, highlighting the shift toward advanced and less invasive testing solutions.

Segmentation Analysis

By Type

The reagents & consumables segment dominated the market with a 67.33% share in 2026, due to continuous usage of test kits and reagents in transplant diagnostics. The instruments segment is expected to grow steadily with rising transplant infrastructure in emerging economies.

By Testing

Rejection monitoring held the largest market share (46.46% in 2026) as these tests are performed repeatedly after transplantation to ensure long-term graft survival.

By Technology

PCR technology accounted for 26.71% of the market share in 2026, owing to its cost-effectiveness and widespread availability. Meanwhile, NGS is expected to register the highest growth rate due to its superior accuracy and role in personalized medicine.

By Transplant Type

The solid organ transplant segment dominated the market with a 95.21% share in 2026, driven by the high prevalence of chronic diseases requiring organ replacement.

By End-user

Hospitals and transplant centers held the largest market share due to the high concentration of transplant procedures and access to advanced diagnostic infrastructure.

Regional Outlook

In 2025, North America generated USD 1.57 billion in revenue, supported by strong government initiatives, advanced diagnostics adoption, and a large transplant patient base. Europe shows steady growth due to strong research collaborations, while Asia Pacific is projected to record the fastest CAGR, driven by rising chronic disease burden and expanding transplant programs in India, China, and Japan. Latin America and the Middle East & Africa are expected to witness moderate growth with improving healthcare infrastructure.

Competitive Landscape

The market is moderately consolidated, with key players such as Thermo Fisher Scientific, Illumina, Qiagen, and F. Hoffmann-La Roche Ltd. leading through technological innovation, strategic partnerships, and product launches. Other prominent players include Bio-Rad Laboratories, Werfen, BD, and Bruker, contributing to competitive expansion.

Conclusion

The global transplant diagnostics market is expected to witness sustained growth from USD 2.69 billion in 2025 to USD 4.45 billion by 2034, driven by rising organ transplant procedures, advancements in molecular diagnostics, and increasing investments in transplant infrastructure. While challenges such as donor organ shortages and regulatory complexities persist, the growing shift toward non-invasive monitoring and precision diagnostics is strengthening market potential. Overall, transplant diagnostics remain essential for improving transplant success rates and long-term patient outcomes, ensuring steady market expansion over the forecast period.

Segmentation By Type

  • Instruments
  • Reagents & Consumables
  • Software & Service

By Testing

  • HLA Typing
  • Crossmatch Testing
  • Donor-Specific Antibody (DSA) Screening
  • Rejection Monitoring
  • Infection & Graft Monitoring

By Technology

  • PCR
  • Next-Generation Sequencing
  • Sanger Sequencing
  • Flow Cytometry
  • Serological Assays
  • Others

By Transplant Type

  • Solid Organ Transplantation
    • Kidney
    • Liver
    • Lung
    • Others
    • Stem Cell / Bone Marrow Transplantation

By End-user

  • Hospitals & Transplant Centers
  • Research & Academic Institutions
  • Others

By Region

  • North America (By Type, Testing, Technology, Transplant Type, End-user, and Country)
    • U.S. (By Transplant Type)
    • Canada (By Transplant Type)
  • Europe (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • Germany (By Transplant Type)
    • U.K. (By Transplant Type)
    • France (By Transplant Type)
    • Spain (By Transplant Type)
    • Italy (By Transplant Type)
    • Rest of Europe (By Transplant Type)
  • Asia Pacific (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • China (By Transplant Type)
    • Japan (By Transplant Type)
    • India (By Transplant Type)
    • Australia (By Transplant Type)
    • South Korea (By Transplant Type)
    • Rest of Asia Pacific (By Transplant Type)
  • Latin America (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • Brazil (By Transplant Type)
    • Mexico (By Transplant Type)
    • Rest of Latin America (By Transplant Type)
  • Middle East & Africa (By Type, Testing, Technology, Transplant Type, End-user, and Country/Sub-region)
    • GCC (By Transplant Type)
    • South Africa (By Transplant Type)
  • Rest of the Middle East & Africa (By Transplant Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2025
  • 4.2. Technological Advancements in Transplant Diagnostics
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Consumables
    • 5.1.3. Software & Service
  • 5.2. Market Analysis, Insights and Forecast - By Testing
    • 5.2.1. HLA Typing
    • 5.2.2. Crossmatch Testing
    • 5.2.3. Donor-Specific Antibody (DSA) Screening
    • 5.2.4. Rejection Monitoring
    • 5.2.5. Infection & Graft Monitoring
  • 5.3. Market Analysis, Insights and Forecast - By Technology
    • 5.3.1. PCR
    • 5.3.2. Next-Generation Sequencing
    • 5.3.3. Sanger Sequencing
    • 5.3.4. Flow Cytometry
    • 5.3.5. Serological Assays
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 5.4.1. Solid Organ Transplantation
      • 5.4.1.1. Kidney
      • 5.4.1.2. Liver
      • 5.4.1.3. Lung
      • 5.4.1.4. Others
    • 5.4.2. Stem Cell / Bone Marrow Transplantation
  • 5.5. Market Analysis, Insights and Forecast - By End-User
    • 5.5.1. Hospitals & Transplant Centers
    • 5.5.2. Research & Academic Institutions
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East and Africa

6. North America Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Consumables
    • 6.1.3. Software & Service
  • 6.2. Market Analysis, Insights and Forecast - By Testing
    • 6.2.1. HLA Typing
    • 6.2.2. Crossmatch Testing
    • 6.2.3. Donor-Specific Antibody (DSA) Screening
    • 6.2.4. Rejection Monitoring
    • 6.2.5. Infection & Graft Monitoring
  • 6.3. Market Analysis, Insights and Forecast - By Technology
    • 6.3.1. PCR
    • 6.3.2. Next-Generation Sequencing
    • 6.3.3. Sanger Sequencing
    • 6.3.4. Flow Cytometry
    • 6.3.5. Serological Assays
    • 6.3.6. Others
  • 6.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 6.4.1. Solid Organ Transplantation
      • 6.4.1.1. Kidney
      • 6.4.1.2. Liver
      • 6.4.1.3. Lung
      • 6.4.1.4. Others
    • 6.4.2. Stem Cell / Bone Marrow Transplantation
  • 6.5. Market Analysis, Insights and Forecast - By End-User
    • 6.5.1. Hospitals & Transplant Centers
    • 6.5.2. Research & Academic Institutions
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Transplant Type
    • 6.6.2. Canada
      • 6.6.2.1. By Transplant Type

7. Europe Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Software & Service
  • 7.2. Market Analysis, Insights and Forecast - By Testing
    • 7.2.1. HLA Typing
    • 7.2.2. Crossmatch Testing
    • 7.2.3. Donor-Specific Antibody (DSA) Screening
    • 7.2.4. Rejection Monitoring
    • 7.2.5. Infection & Graft Monitoring
  • 7.3. Market Analysis, Insights and Forecast - By Technology
    • 7.3.1. PCR
    • 7.3.2. Next-Generation Sequencing
    • 7.3.3. Sanger Sequencing
    • 7.3.4. Flow Cytometry
    • 7.3.5. Serological Assays
    • 7.3.6. Others
  • 7.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 7.4.1. Solid Organ Transplantation
      • 7.4.1.1. Kidney
      • 7.4.1.2. Liver
      • 7.4.1.3. Lung
      • 7.4.1.4. Others
    • 7.4.2. Stem Cell / Bone Marrow Transplantation
  • 7.5. Market Analysis, Insights and Forecast - By End-User
    • 7.5.1. Hospitals & Transplant Centers
    • 7.5.2. Research & Academic Institutions
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Transplant Type
    • 7.6.2. Germany
      • 7.6.2.1. By Transplant Type
    • 7.6.3. France
      • 7.6.3.1. By Transplant Type
    • 7.6.4. Spain
      • 7.6.4.1. By Transplant Type
    • 7.6.5. Italy
      • 7.6.5.1. By Transplant Type
    • 7.6.6. Rest of Europe
      • 7.6.6.1. By Transplant Type

8. Asia Pacific Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Consumables
    • 8.1.3. Software & Service
  • 8.2. Market Analysis, Insights and Forecast - By Testing
    • 8.2.1. HLA Typing
    • 8.2.2. Crossmatch Testing
    • 8.2.3. Donor-Specific Antibody (DSA) Screening
    • 8.2.4. Rejection Monitoring
    • 8.2.5. Infection & Graft Monitoring
  • 8.3. Market Analysis, Insights and Forecast - By Technology
    • 8.3.1. PCR
    • 8.3.2. Next-Generation Sequencing
    • 8.3.3. Sanger Sequencing
    • 8.3.4. Flow Cytometry
    • 8.3.5. Serological Assays
    • 8.3.6. Others
  • 8.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 8.4.1. Solid Organ Transplantation
      • 8.4.1.1. Kidney
      • 8.4.1.2. Liver
      • 8.4.1.3. Lung
      • 8.4.1.4. Others
    • 8.4.2. Stem Cell / Bone Marrow Transplantation
  • 8.5. Market Analysis, Insights and Forecast - By End-User
    • 8.5.1. Hospitals & Transplant Centers
    • 8.5.2. Research & Academic Institutions
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Transplant Type
    • 8.6.2. Australia
      • 8.6.2.1. By Transplant Type
    • 8.6.3. China
      • 8.6.3.1. By Transplant Type
    • 8.6.4. India
      • 8.6.4.1. By Transplant Type
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Transplant Type
    • 8.6.6. South Korea
      • 8.6.6.1. By Transplant Type
    • 8.6.7. Rest of Asia Pacific
      • 8.6.7.1. By Transplant Type

9. Latin America Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Consumables
    • 9.1.3. Software & Service
  • 9.2. Market Analysis, Insights and Forecast - By Testing
    • 9.2.1. HLA Typing
    • 9.2.2. Crossmatch Testing
    • 9.2.3. Donor-Specific Antibody (DSA) Screening
    • 9.2.4. Rejection Monitoring
    • 9.2.5. Infection & Graft Monitoring
  • 9.3. Market Analysis, Insights and Forecast - By Technology
    • 9.3.1. PCR
    • 9.3.2. Next-Generation Sequencing
    • 9.3.3. Sanger Sequencing
    • 9.3.4. Flow Cytometry
    • 9.3.5. Serological Assays
    • 9.3.6. Others
  • 9.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 9.4.1. Solid Organ Transplantation
      • 9.4.1.1. Kidney
      • 9.4.1.2. Liver
      • 9.4.1.3. Lung
      • 9.4.1.4. Others
    • 9.4.2. Stem Cell / Bone Marrow Transplantation
  • 9.5. Market Analysis, Insights and Forecast - By End-User
    • 9.5.1. Hospitals & Transplant Centers
    • 9.5.2. Research & Academic Institutions
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Transplant Type
    • 9.6.2. Mexico
      • 9.6.2.1. By Transplant Type
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Transplant Type

10. Middle East and Africa Transplant Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Consumables
    • 10.1.3. Software & Service
  • 10.2. Market Analysis, Insights and Forecast - By Testing
    • 10.2.1. HLA Typing
    • 10.2.2. Crossmatch Testing
    • 10.2.3. Donor-Specific Antibody (DSA) Screening
    • 10.2.4. Rejection Monitoring
    • 10.2.5. Infection & Graft Monitoring
  • 10.3. Market Analysis, Insights and Forecast - By Technology
    • 10.3.1. PCR
    • 10.3.2. Next-Generation Sequencing
    • 10.3.3. Sanger Sequencing
    • 10.3.4. Flow Cytometry
    • 10.3.5. Serological Assays
    • 10.3.6. Others
  • 10.4. Market Analysis, Insights and Forecast - By Transplant Type
    • 10.4.1. Solid Organ Transplantation
      • 10.4.1.1. Kidney
      • 10.4.1.2. Liver
      • 10.4.1.3. Lung
      • 10.4.1.4. Others
    • 10.4.2. Stem Cell / Bone Marrow Transplantation
  • 10.5. Market Analysis, Insights and Forecast - By End-User
    • 10.5.1. Hospitals & Transplant Centers
    • 10.5.2. Research & Academic Institutions
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
      • 10.6.1.1. By Transplant Type
    • 10.6.2. GCC
      • 10.6.2.1. By Transplant Type
    • 10.6.3. Rest of Middle East and Africa
      • 10.6.3.1. By Transplant Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Hoffmann-La Roche Ltd.
    • 11.2.2. Illumina Inc.
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Qiagen
    • 11.2.5. Admera Health, LLC
    • 11.2.6. Bio-Rad Laboratories Inc.
    • 11.2.7. Bruker
    • 11.2.8. Werfen
    • 11.2.9. BD
    • 11.2.10. Other Prominent Players

List of Tables

  • Table 1: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 2: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 3: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 4: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 5: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 6: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 7: Global Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Region, 2021-2034
  • Table 8: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 9: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 10: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 11: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 12: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 13: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 14: North America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country, 2021-2034
  • Table 15: U.S. Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 16: Canada Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 17: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 18: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 19: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 20: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 21: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 22: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 23: Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 24: UK Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 25: Germany Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 26: France Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 27: Italy Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 28: Spain Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 29: Scandinavia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 30: Rest of Europe Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 33: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 34: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 35: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 36: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 37: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 38: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 39: Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 40: China Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 41: Japan Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 42: India Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 43: Australia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 44: South Korea Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 45: Southeast Asia Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 46: Rest of Asia Pacific Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 48: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 49: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 50: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 51: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 52: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 53: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 54: Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 55: Brazil Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 56: Mexico Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 57: Rest of Latin America Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 62: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Type, 2021-2034
  • Table 63: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Testing, 2021-2034
  • Table 64: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Technology, 2021-2034
  • Table 65: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 66: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Solid Organ Transplantation, 2021-2034
  • Table 67: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by End-User, 2021-2034
  • Table 68: Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Country/Sub-region, 2021-2034
  • Table 69: South Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 70: GCC Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034
  • Table 71: Rest of Middle East and Africa Transplant Diagnostics Market Revenue (USD billlion) Forecast, by Transplant Type, 2021-2034

List of Figures

  • Figure 1: Global Transplant Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Transplant Diagnostics Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Transplant Diagnostics Market Value Share (%), by Testing, 2025 & 2034
  • Figure 4: Global Transplant Diagnostics Market Value Share (%), by Technology, 2025 & 2034
  • Figure 5: Global Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025 & 2034
  • Figure 6: Global Transplant Diagnostics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Transplant Diagnostics Market Value (USD billlion), by Region, 2025 & 2034
  • Figure 8: North America Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 9: North America Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 10: North America Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 11: North America Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 12: North America Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 13: North America Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 14: North America Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 15: North America Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 16: North America Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 17: North America Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 18: North America Transplant Diagnostics Market Value (USD billlion), By Country, 2025 & 2034
  • Figure 19: North America Transplant Diagnostics Market Value Share (%), By Country, 2025
  • Figure 20: Europe Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 21: Europe Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 22: Europe Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 23: Europe Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 24: Europe Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 25: Europe Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 26: Europe Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 27: Europe Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 28: Europe Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 29: Europe Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 33: Asia Pacific Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 34: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 35: Asia Pacific Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 36: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 37: Asia Pacific Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 38: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 39: Asia Pacific Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 40: Asia Pacific Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44: Latin America Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 45: Latin America Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 46: Latin America Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 47: Latin America Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 48: Latin America Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 49: Latin America Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 50: Latin America Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 51: Latin America Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 52: Latin America Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 53: Latin America Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Type, 2025 & 2034
  • Figure 57: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Type, 2025
  • Figure 58: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Testing, 2025 & 2034
  • Figure 59: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Testing, 2025
  • Figure 60: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Technology, 2025 & 2034
  • Figure 61: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 62: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by Transplant Type, 2025 & 2034
  • Figure 63: Middle East and Africa Transplant Diagnostics Market Value Share (%), by Transplant Type, 2025
  • Figure 64: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), by End-user, 2025 & 2034
  • Figure 65: Middle East and Africa Transplant Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East and Africa Transplant Diagnostics Market Value (USD billlion), By Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East and Africa Transplant Diagnostics Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68: Global Transplant Diagnostics Market Share (%), By Company, 2025